Adaptive Biotechnologies Corporation
US ˙ NasdaqGS ˙ US00650F1093

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Kevin T Conroy. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Kevin T Conroy har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:ALGN / Align Technology, Inc. Director 1 808
US:EXAS / Exact Sciences Corporation President and CEO, Director 0
US:ADPT / Adaptive Biotechnologies Corporation Director 22 968
US:EPZM / Epizyme Inc Director 0
US:US83444K1135 / SomaLogic Inc Director 0
Director 0
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Kevin T Conroy. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp ADPT / Adaptive Biotechnologies Corporation - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i ADPT / Adaptive Biotechnologies Corporation. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

ADPT / Adaptive Biotechnologies Corporation Insider Trades
Internhandel ADPT / Adaptive Biotechnologies Corporation - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i ADPT / Adaptive Biotechnologies Corporation. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

ADPT / Adaptive Biotechnologies Corporation Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Kevin T Conroy som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-05-22 2025-05-21 4 ALGN ALIGN TECHNOLOGY INC
Common Stock
M - Exercise 1 148 1 808 173,94
2025-04-29 2019-11-27 5/A EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −22 063 0 −100,00
2025-04-29 2019-11-27 5/A EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −43 126 22 063 −66,16
2025-04-29 2019-11-27 5/A EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 43 126 893 818 5,07
2025-04-29 2019-05-06 5/A EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −28 660 850 692 −3,26
2025-04-29 2020-10-26 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −163 000 602 120 −21,30
2025-04-29 2024-05-14 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −74 599 779 944 −8,73
2025-03-10 2025-03-07 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes −48 929 1 154 340 −4,07 47,06 −2 302 599 54 323 240
2025-03-10 2025-03-07 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 66 723 1 203 269 5,87 22,38 1 493 261 26 929 160
2025-03-04 2025-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes −10 419 1 136 546 −0,91 47,82 −498 237 54 349 630
2025-03-04 2025-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 22 167 1 146 965 1,97
2025-03-04 2025-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes −8 528 1 124 798 −0,75 47,82 −407 809 53 787 840
2025-03-04 2025-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 18 143 1 133 326 1,63
2025-02-26 2025-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes −6 195 1 115 183 −0,55 51,28 −317 680 57 186 584
2025-02-26 2025-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 13 180 1 121 378 1,19
2025-02-21 2025-02-20 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes −21 140 1 108 198 −1,87 50,48 −1 067 147 55 941 835
2025-02-21 2025-02-20 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 48 044 1 129 338 4,44
2025-02-21 2025-02-19 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes −3 271 1 081 294 −0,30 49,63 −162 340 53 664 621
2025-02-21 2025-02-19 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 10 374 1 084 565 0,97
2024-11-13 2024-11-13 4 EXAS EXACT SCIENCES CORP
Common Stock
P - Purchase 19 500 1 074 191 1,85 51,35 1 001 325 55 159 708
2024-05-24 2024-05-22 4 ALGN ALIGN TECHNOLOGY INC
Common Stock
M - Exercise 660 660
2024-05-02 2024-05-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −1 155 1 156 191 −0,10 60,15 −69 473 69 544 889
2024-05-02 2024-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 708 1 157 346 0,06 30,02 21 254 34 743 527
2024-05-02 2024-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2 489 1 156 638 0,22
2024-03-04 2024-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −8 271 1 299 496 −0,63 59,32 −490 636 77 086 103
2024-03-04 2024-02-29 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 18 143 1 307 767 1,41
2024-02-28 2024-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −6 263 1 289 624 −0,48 56,89 −356 302 73 366 709
2024-02-28 2024-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 13 181 1 295 887 1,03
2024-02-26 2024-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes −61 560 1 282 706 −4,58 57,53 −3 541 547 73 794 076
2024-02-26 2024-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 102 837 1 344 266 8,28 13,96 1 435 605 18 765 953
2024-02-23 2024-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −11 565 1 241 429 −0,92 59,78 −691 356 74 212 626
2024-02-23 2024-02-21 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 23 238 1 252 994 1,89
2024-02-22 2024-02-21 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −4 975 1 229 756 −0,40 61,50 −305 962 75 629 994
2024-02-22 2024-02-20 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 10 374 1 234 731 0,85
2024-02-16 2024-02-15 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −14 791 1 224 357 −1,19 61,43 −908 611 75 212 251
2024-02-16 2024-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 31 133 1 239 148 2,58
2024-02-16 2023-05-01 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 709 1 208 015 0,06 30,02 21 284 36 264 610
2023-03-08 2023-03-06 4 ADPT Adaptive Biotechnologies Corp
Common Stock
A - Award 14 775 22 968 180,34
2023-03-01 2023-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −10 416 1 207 306 −0,86 61,12 −636 626 73 790 543
2023-03-01 2023-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9 312 1 217 722 0,77
2023-03-01 2023-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 13 180 1 208 410 1,10
2023-02-23 2023-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −4 764 1 195 230 −0,40 62,72 −298 798 74 964 826
2023-02-23 2023-02-21 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 10 374 1 199 994 0,87
2023-02-16 2023-02-15 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −14 617 1 189 620 −1,21 65,59 −958 729 78 027 176
2023-02-16 2023-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 31 132 1 204 237 2,65
2023-02-14 2023-02-13 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −4 527 1 173 105 −0,38 64,55 −292 218 75 723 928
2023-02-14 2023-02-10 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9 705 1 177 632 0,83
2022-08-16 2022-08-12 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
D - Sale to Issuer −8 994 0 −100,00
2022-08-16 2022-08-12 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
D - Sale to Issuer −53 324 8 994 −85,57
2022-07-06 2022-07-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −7 1 167 927 0,00 40,75 −285 47 593 025
2022-07-06 2022-05-02 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 328 1 167 934 0,03 47,41 15 550 55 371 751
2022-07-05 2022-06-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 10 204 62 318 19,58 1,47 15 000 91 607
2022-05-19 2022-05-17 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 41 006 41 006
2022-05-19 2022-05-17 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 8 994 52 114 20,86
2022-04-01 2022-03-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 13 043 43 120 43,37 1,15 14 999 49 588
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −2 253 66 047 −3,30
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −4 612 235 388 −1,92
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −229 757 0 −100,00
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 2 253 1 167 606 0,19 44,37 99 966 51 806 678
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 4 612 1 165 353 0,40 21,68 99 988 25 264 853
2022-03-18 2022-03-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 229 757 1 160 741 24,68 5,70 1 309 615 6 616 224
2022-03-02 2022-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −14 299 930 984 −1,51 76,69 −1 096 590 71 397 163
2022-03-02 2022-02-28 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −9 312 9 312 −50,00
2022-03-02 2022-02-28 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 575 0 −100,00
2022-03-02 2022-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9 312 945 283 0,99
2022-03-02 2022-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 575 935 971 2,25
2022-03-01 2022-02-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 52 722 52 722
2022-02-25 2022-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −27 126 915 396 −2,88 70,10 −1 901 533 64 169 260
2022-02-25 2022-02-23 4 EXAS EXACT SCIENCES CORP
Performance Stock Units
M - Exercise −58 643 0 −100,00
2022-02-25 2022-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 58 643 942 522 6,63
2022-02-24 2022-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −5 188 883 879 −0,58 69,05 −358 231 61 031 845
2022-02-24 2022-02-22 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −10 373 31 122 −25,00
2022-02-24 2022-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 10 373 889 067 1,18
2022-02-16 2022-02-15 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −14 409 878 694 −1,61 79,55 −1 146 236 69 900 108
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −31 133 62 265 −33,33
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −96 758 0 −100,00
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −94 425 0 −100,00
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 31 133 893 103 3,61 78,33 2 438 648 69 956 758
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 96 758 861 970 12,64 10,82 1 046 922 9 326 515
2022-02-16 2022-02-14 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 94 425 765 212 14,08 9,07 856 435 6 940 473
2022-01-28 2022-01-26 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
A - Award 16 722 16 722
2022-01-28 2022-01-26 4 ADPT Adaptive Biotechnologies Corp
Common Stock
A - Award 6 689 8 193 444,75
2022-01-19 2022-01-14 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 6 407 670 787 0,96
2022-01-04 2021-12-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 6 000 30 077 24,92 2,50 15 000 75 192
2021-11-03 2021-11-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −16 922 664 380 −2,48 93,88 −1 588 637 62 371 994
2021-10-05 2021-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −17 078 681 302 −2,45 93,64 −1 599 184 63 797 119
2021-10-01 2021-09-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 2 930 24 077 13,86 5,12 15 002 123 274
2021-09-03 2021-09-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −18 978 698 380 −2,65 104,42 −1 981 683 72 924 840
2021-09-03 2021-09-01 4 SLGCW SomaLogic, Inc.
Class B Common Stock
M - Exercise −25 000 0 −100,00
2021-09-03 2021-09-01 4 SLGCW SomaLogic, Inc.
Warrants to purchase Class A Common Stock (right to buy)
A - Award 166 666 166 666
2021-09-03 2021-09-01 4 SLGCW SomaLogic, Inc.
Class A Common Stock
J - Other 25 000 25 000
2021-08-04 2021-08-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −19 970 717 358 −2,71 107,50 −2 146 775 77 115 985
2021-07-06 2021-07-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −7 784 737 328 −1,04 123,43 −960 779 91 008 395
2021-07-01 2021-06-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 1 805 21 147 9,33 8,31 15 000 175 732
2021-06-15 2021-06-11 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 40 559 40 559
2021-06-15 2021-06-11 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 8 060 19 342 71,44
2021-06-03 2021-06-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −12 384 745 112 −1,63 111,00 −1 374 624 82 707 432
2021-05-05 2021-05-03 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −19 240 757 496 −2,48 131,09 −2 522 172 99 300 151
2021-05-05 2021-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 328 776 736 0,04 64,74 21 235 50 285 889
2021-04-05 2021-04-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −22 755 776 408 −2,85 132,30 −3 010 486 102 718 778
2021-04-01 2021-03-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 1 723 11 282 18,02 8,71 15 007 98 266
2021-03-03 2021-03-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −9 796 799 163 −1,21 138,42 −1 355 962 110 620 142
2021-03-03 2021-03-01 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 575 20 575 −50,00
2021-03-03 2021-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 575 808 959 2,61
2021-03-02 2021-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −26 958 788 384 −3,31 136,79 −3 687 585 107 843 047
2021-03-02 2021-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −4 335 815 342 −0,53 137,44 −595 802 112 060 604
2021-03-02 2021-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −9 312 18 624 −33,33
2021-03-02 2021-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9 312 819 677 1,15
2021-02-25 2021-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −16 420 810 365 −1,99 136,30 −2 238 046 110 452 750
2021-02-25 2021-02-23 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −34 325 0 −100,00
2021-02-25 2021-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 34 325 826 785 4,33
2021-02-23 2021-02-19 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 41 495 41 495
2021-02-18 2021-02-17 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −15 825 792 460 −1,96 142,66 −2 257 594 113 052 344
2021-02-18 2021-02-16 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −31 132 93 398 −25,00
2021-02-18 2021-02-16 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 31 132 808 285 4,01
2021-02-17 2021-02-14 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
A - Award 3 759 3 759
2021-02-17 2021-02-14 4 ADPT Adaptive Biotechnologies Corp
Common Stock
A - Award 1 504 1 504
2021-02-09 2021-02-05 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −17 543 229 757 −7,09
2021-02-09 2021-02-05 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 17 543 777 153 2,31 5,70 99 995 4 429 772
2021-02-03 2021-02-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −30 344 759 610 −3,84 138,07 −4 189 596 104 879 353
2021-02-03 2020-12-28 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −35 750 789 954 −4,33
2021-01-07 2021-01-04 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −31 814 825 704 −3,71 128,74 −4 095 734 106 301 133
2021-01-05 2020-12-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 1 024 9 559 12,00 10,86 11 121 103 811
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −100 857 518 −0,01 126,59 −12 659 108 553 204
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −100 857 618 −0,01 126,49 −12 649 108 480 101
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −7 043 857 718 −0,81 125,92 −886 855 108 003 851
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −10 840 864 761 −1,24 124,88 −1 353 699 107 991 354
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −7 776 875 601 −0,88 124,03 −964 457 108 600 792
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −2 918 883 377 −0,33 122,91 −358 651 108 575 867
2020-12-02 2020-12-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −1 800 886 295 −0,20 122,05 −219 690 108 172 305
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −400 888 095 −0,05 124,71 −49 884 110 754 327
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −600 888 495 −0,07 123,45 −74 070 109 684 708
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −9 577 889 095 −1,07 122,33 −1 171 554 108 762 991
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −10 229 898 672 −1,13 121,52 −1 243 028 109 206 621
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −6 512 908 901 −0,71 120,45 −784 370 109 477 125
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −1 108 915 413 −0,12 119,18 −132 051 109 098 921
2020-11-03 2020-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −4 393 916 521 −0,48 118,32 −519 780 108 442 765
2020-10-02 2020-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −1 136 920 914 −0,12 105,20 −119 507 96 880 153
2020-10-02 2020-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −5 200 922 050 −0,56 104,70 −544 440 96 538 635
2020-10-02 2020-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −9 391 927 250 −1,00 103,57 −972 626 96 035 282
2020-10-02 2020-10-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −11 698 936 641 −1,23 102,86 −1 203 256 96 342 893
2020-10-01 2020-09-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 933 8 535 12,27 11,93 11 131 101 823
2020-09-02 2020-09-01 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −19 927 948 339 −2,06 75,03 −1 495 123 71 153 875
2020-08-04 2020-08-03 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −198 968 266 −0,02 95,00 −18 810 91 985 270
2020-08-04 2020-08-03 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −25 000 968 464 −2,52 93,79 −2 344 750 90 832 239
2020-08-04 2020-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 501 993 464 0,05 42,44 21 262 42 162 612
2020-07-06 2020-07-01 4 ARYA ARYA SCIENCES ACQUISITION CORP.
Class B Ordinary Shares
D - Sale to Issuer −30 000 0 −100,00
2020-07-01 2020-06-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 693 7 602 10,03 16,06 11 130 122 088
2020-06-02 2020-05-29 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 14 013 14 013
2020-04-02 2020-03-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 717 6 909 11,58 15,51 11 121 107 159
2020-03-02 2020-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −9 750 992 963 −0,97 80,17 −781 658 79 605 844
2020-03-02 2020-02-27 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 575 41 150 −33,33
2020-03-02 2020-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 575 1 002 713 2,09
2020-02-28 2020-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −13 875 982 138 −1,39 80,27 −1 113 746 78 836 217
2020-02-28 2020-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −9 312 27 936 −25,00
2020-02-28 2020-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 025 0 −100,00
2020-02-28 2020-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9 312 996 013 0,94
2020-02-28 2020-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 025 986 701 2,07
2020-02-26 2020-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −18 115 966 676 −1,84 85,11 −1 541 768 82 273 794
2020-02-26 2020-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −34 325 34 325 −50,00
2020-02-26 2020-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 34 325 984 791 3,61
2020-02-18 2020-02-13 4 ADPT Adaptive Biotechnologies Corp
Stock Option (Right to Buy)
A - Award 8 888 8 888
2020-02-18 2020-02-14 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 124 530 124 530
2020-02-18 2020-02-14 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 100 916 100 916
2020-02-14 2019-11-27 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 21 729 21 729
2020-02-14 2019-11-27 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 21 730 21 730
2020-02-14 2019-11-27 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 21 730 21 730
2020-02-14 2019-11-27 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −65 189 0 −100,00
2020-01-03 2019-12-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 452 6 192 7,87 24,60 11 119 152 323
2019-12-18 2019-12-16 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −4 277 66 723 −6,02
2019-12-18 2019-12-16 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −7 163 102 837 −6,51
2019-12-18 2019-12-16 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 4 277 950 466 0,45 23,38 99 996 22 221 895
2019-12-18 2019-12-16 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 7 163 946 189 0,76 13,96 99 995 13 208 798
2019-12-18 2019-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 500 939 026 0,05 42,44 21 220 39 852 263
2019-10-02 2019-09-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 1 078 5 740 23,12 10,32 11 125 59 237
2019-07-02 2019-06-30 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 887 4 662 23,50 12,55 11 132 58 508
2019-06-07 2019-05-31 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 17 633 17 633
2019-06-07 2019-03-31 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 897 3 775 31,17 12,39 11 114 46 772
2019-03-12 2019-03-11 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −11 227 938 526 −1,18 87,21 −979 129 81 850 730
2019-03-12 2019-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −24 400 0 −100,00
2019-03-12 2019-03-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 24 400 949 753 2,64
2019-03-01 2019-02-28 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −10 014 925 353 −1,07 93,20 −933 345 86 246 601
2019-02-28 2019-02-27 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 575 61 725 −25,00
2019-02-28 2019-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 575 935 367 2,25
2019-02-28 2019-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −9 169 914 792 −0,99 95,07 −871 734 86 972 935
2019-02-28 2019-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 37 248 37 248
2019-02-28 2019-02-26 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 34 110 34 110
2019-02-28 2019-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 025 20 025 −50,00
2019-02-28 2019-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 025 923 961 2,22
2019-02-26 2019-02-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −16 400 903 936 −1,78 90,55 −1 485 036 81 852 309
2019-02-26 2019-02-23 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −34 325 68 650 −33,33
2019-02-26 2019-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 34 325 920 336 3,87
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −23 236 886 011 −2,56 82,49 −1 916 668 73 084 389
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −181 250 909 247 −16,62 81,90 −14 844 194 74 466 420
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −36 453 1 090 497 −3,23 80,78 −2 944 783 88 093 619
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −28 605 1 126 950 −2,48 79,89 −2 285 339 90 035 416
2019-01-25 2019-01-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −34 853 1 155 555 −2,93 78,80 −2 746 416 91 057 734
2019-01-25 2019-01-24 4 EXAS EXACT SCIENCES CORP
Performance Share Units
M - Exercise −304 397 0 −100,00
2019-01-25 2019-01-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 304 397 1 190 408 34,36
2019-01-04 2019-01-02 4 EXAS EXACT SCIENCES CORP
Performance Share Units
A - Award 304 397 304 397
2018-11-14 2018-11-12 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −163 514 0 −100,00
2018-11-14 2018-11-12 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −163 514 886 011 −15,58 69,00 −11 282 466 61 134 759
2018-11-14 2018-11-12 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 163 514 1 049 525 18,46 0,83 135 717 871 106
2018-11-14 2018-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 3 572 886 011 0,40 5,95 21 253 5 271 765
2018-07-02 2018-07-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001
A - Award 2 878 2 878 13,55 38 997 38 997
2018-05-31 2018-05-18 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 12 500 12 500
2018-03-13 2018-03-12 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −11 459 882 439 −1,28 52,19 −598 091 46 058 021
2018-03-13 2018-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −24 400 24 400 −50,00
2018-03-13 2018-03-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 24 400 893 898 2,81
2018-02-28 2018-02-27 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 82 300 82 300
2018-02-28 2018-02-27 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 68 300 68 300
2018-02-28 2018-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −9 085 869 498 −1,03 44,10 −400 630 38 343 123
2018-02-28 2018-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 025 40 050 −33,33
2018-02-28 2018-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 025 878 583 2,33
2018-02-27 2018-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −25 319 858 558 −2,86 42,34 −1 071 956 36 349 629
2018-02-27 2018-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −19 500 0 −100,00
2018-02-27 2018-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19 500 883 877 2,26
2018-02-27 2018-02-23 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −34 325 102 975 −25,00
2018-02-27 2018-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 34 325 864 377 4,14
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −101 488 163 514 −38,30
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −9 458 830 052 −1,13 46,29 −437 839 38 425 597
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −50 504 839 510 −5,67 46,54 −2 350 456 39 070 795
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −41 526 890 014 −4,46 44,60 −1 851 977 39 692 844
2018-02-13 2018-02-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 101 488 931 540 12,23 0,83 84 235 773 178
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −110 439 265 002 −29,42
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −30 036 830 052 −3,49 51,66 −1 551 660 42 880 486
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −41 588 860 088 −4,61 50,72 −2 109 427 43 625 384
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −26 738 901 676 −2,88 49,54 −1 324 707 44 672 636
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −12 077 928 414 −1,28 48,87 −590 167 45 368 807
2018-01-25 2018-01-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 110 439 940 491 13,31 0,83 91 664 780 608
2018-01-17 2018-01-12 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −125 402 375 441 −25,04
2018-01-17 2018-01-12 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −25 912 830 052 −3,03 53,24 −1 379 659 44 195 289
2018-01-17 2018-01-12 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −99 490 855 964 −10,41 52,68 −5 240 934 45 090 472
2018-01-17 2018-01-12 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 125 402 955 454 15,11 0,83 104 084 793 027
2017-12-26 2017-12-22 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −123 512 500 843 −19,78
2017-12-26 2017-12-22 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −27 065 830 052 −3,16 53,36 −1 444 053 44 287 424
2017-12-26 2017-12-22 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −96 447 857 117 −10,11 52,37 −5 050 736 44 885 503
2017-12-26 2017-12-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 123 512 953 564 14,88 0,83 102 515 791 458
2017-12-08 2017-12-06 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −121 849 624 355 −16,33
2017-12-08 2017-12-06 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −28 370 830 052 −3,30 53,80 −1 526 448 44 660 948
2017-12-08 2017-12-06 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −93 479 858 422 −9,82 53,35 −4 986 731 45 793 380
2017-12-08 2017-12-06 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 121 849 951 901 14,68 0,83 101 135 790 078
2017-11-22 2017-11-21 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −134 057 746 204 −15,23
2017-11-22 2017-11-21 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −134 057 830 052 −13,90 59,50 −7 976 660 49 389 754
2017-11-22 2017-11-21 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 134 057 964 109 16,15 0,83 111 267 800 210
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −137 815 880 261 −13,54
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −5 424 830 052 −0,65 60,05 −325 690 49 841 302
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −80 405 835 486 −8,78 59,43 −4 778 550 49 653 768
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −51 976 915 891 −5,37 58,59 −3 045 430 53 664 801
2017-11-13 2017-11-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 137 815 967 867 16,60 0,83 114 386 803 330
2017-08-17 2017-08-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −9 242 96 758 −8,72
2017-08-17 2017-08-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 9 242 830 052 1,13 10,82 99 998 8 981 163
2017-07-28 2017-07-27 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 137 300 137 300
2017-07-28 2017-07-27 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 240 000 240 000
2017-07-28 2017-05-01 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 3 571 820 810 0,44 5,95 21 247 4 883 820
2017-03-14 2017-03-13 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −12 059 817 239 −1,45 21,16 −255 168 17 292 777
2017-03-13 2017-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −24 400 48 800 −33,33
2017-03-13 2017-03-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 24 400 829 298 3,03
2017-02-28 2017-02-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −19 557 804 898 −2,37 21,48 −420 084 17 289 209
2017-02-28 2017-02-26 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 025 60 075 −25,00
2017-02-28 2017-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 025 824 455 2,49
2017-02-28 2017-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −19 500 19 500 −50,00
2017-02-28 2017-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19 500 804 430 2,48
2017-02-28 2017-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −7 577 784 930 −0,96 21,57 −163 436 16 930 940
2017-02-24 2017-02-22 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −19 375 0 −100,00
2017-02-24 2017-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19 375 792 507 2,51
2017-02-07 2017-02-06 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 25 000 25 000
2016-11-15 2016-11-15 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −33 075 94 425 −25,94
2016-11-15 2016-11-15 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 33 075 773 132 4,47 9,07 299 990 7 012 307
2016-11-15 2016-11-15 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −275 000 740 057 −27,09 17,36 −4 774 000 12 847 390
2016-11-15 2016-11-14 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −275 000 1 015 057 −21,32 17,52 −4 818 000 17 783 799
2016-11-15 2016-11-11 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −600 000 1 018 076 −37,08
2016-11-15 2016-11-11 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale −50 000 1 290 057 −3,73 17,68 −884 000 22 808 208
2016-11-15 2016-11-11 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 600 000 1 340 057 81,07 0,83 498 000 1 112 247
2016-07-27 2016-07-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −25 000 0 −100,00
2016-07-27 2016-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 25 000 740 057 3,50
2016-07-27 2016-05-02 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2 750 715 057 0,39 5,95 16 362 4 254 589
2016-03-11 2016-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −24 400 73 200 −25,00
2016-03-11 2016-03-09 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 24 400 712 307 3,55
2016-03-11 2016-02-26 4/A EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 80 100 80 100
2016-03-11 2016-02-26 4/A EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 247 300 247 300
2016-03-11 2016-02-26 4/A EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −6 895 637 907 −1,07 5,81 −40 060 3 706 240
2016-03-01 2016-03-01 4 EXAS EXACT SCIENCES CORP
Common Stock
P - Purchase X 50 000 687 907 7,84 5,00 250 000 3 439 535
2016-02-29 2016-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −6 895 637 907 −1,07 5,81 −40 060 3 706 240
2016-02-26 2016-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −19 500 39 000 −33,33
2016-02-26 2016-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19 500 644 802 3,12
2016-02-24 2016-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −6 866 625 302 −1,09 6,39 −43 874 3 995 680
2016-02-24 2016-02-22 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −19 375 19 375 −50,00
2016-02-24 2016-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19 375 632 168 3,16
2016-01-13 2016-01-11 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −265 924 1 618 076 −14,11
2016-01-13 2016-01-11 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 265 924 612 973 76,62 0,83 220 717 508 768
2016-01-05 2016-01-04 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −10 750 346 869 −3,01 8,72 −93 740 3 024 698
2016-01-05 2015-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 466 0 −100,00
2016-01-05 2015-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 466 357 619 6,07
2016-01-05 2015-09-21 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −787 337 153 −0,23
2016-01-05 2015-06-30 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −340 337 940 −0,10
2016-01-05 2015-04-21 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −1 000 338 280 −0,29
2016-01-05 2015-02-18 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −395 339 280 −0,12
2015-12-28 2015-12-23 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −81 000 1 884 000 −4,12
2015-12-28 2015-12-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 81 000 338 335 31,48 0,83 67 230 280 818
2015-07-28 2015-07-27 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −11 386 257 335 −4,24 24,04 −273 719 6 186 333
2015-07-28 2015-07-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −25 000 25 000 −50,00
2015-07-28 2015-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 25 000 268 721 10,26
2015-07-28 2015-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 1 195 244 061 0,49 17,78 21 247 4 339 405
2015-03-11 2015-03-09 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 97 600 97 600
2015-03-11 2015-03-09 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 71 000 71 000
2015-02-26 2015-02-26 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −8 425 243 866 −3,34 23,44 −197 482 5 716 219
2015-02-26 2015-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −19 500 58 500 −25,00
2015-02-26 2015-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19 500 252 291 8,38
2015-02-25 2015-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −9 798 232 791 −4,04 22,90 −224 374 5 330 914
2015-02-25 2015-02-23 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −19 375 38 750 −33,33
2015-02-25 2015-02-23 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19 375 242 589 8,68
2015-01-05 2015-01-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −9 484 223 214 −4,08 26,72 −253 412 5 964 278
2015-01-05 2014-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 467 20 466 −50,00
2015-01-05 2014-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 467 232 698 9,64
2015-01-05 2014-10-28 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −1 025 212 231 −0,48
2015-01-05 2014-07-07 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −583 213 256 −0,27
2015-01-05 2014-06-09 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift 65 189 65 189
2015-01-05 2014-06-09 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −65 189 213 839 −23,36
2015-01-05 2014-03-14 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −1 535 279 028 −0,55
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise −135 000 1 965 000 −6,43
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise X −133 334 2 100 000 −5,97
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 135 000 280 563 92,74 0,83 112 050 232 867
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −133 334 145 563 −47,81 23,93 −3 190 989 3 483 657
2014-10-20 2014-10-20 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 133 334 278 897 91,60 0,83 110 667 231 485
2014-10-20 2014-10-17 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise X −133 333 2 233 334 −5,63
2014-10-20 2014-10-17 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −133 333 145 563 −47,81 23,68 −3 157 632 3 447 267
2014-10-20 2014-10-17 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 133 333 278 896 91,60 0,83 110 666 231 484
2014-10-20 2014-10-16 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
M - Exercise X −133 333 2 366 667 −5,33
2014-10-20 2014-10-16 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −133 333 145 563 −47,81 22,84 −3 045 566 3 324 921
2014-10-20 2014-10-16 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise X 133 333 278 896 91,60 0,83 110 666 231 484
2014-07-29 2014-07-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −25 000 50 000 −33,33
2014-07-29 2014-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −11 336 145 563 −7,23 15,99 −181 263 2 327 552
2014-07-29 2014-07-25 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 25 000 156 899 18,95
2014-07-29 2014-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2 721 131 899 2,11 7,81 21 251 1 030 131
2014-06-20 2013-11-12 5 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −4 092 118 511 −3,34
2014-02-25 2014-02-24 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 78 000 78 000
2014-02-25 2014-02-24 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 110 000 110 000
2014-02-25 2014-02-24 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −8 708 134 374 −6,09 14,07 −122 522 1 890 642
2014-02-25 2014-02-22 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 19 375 143 082 15,66
2014-01-03 2014-01-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −9 271 123 707 −6,97 11,96 −110 881 1 479 536
2014-01-03 2014-01-02 4 EXAS EXACT SCIENCES CORP
Common Stock
S - Sale X −17 108 112 511 −13,20 11,96 −204 612 1 345 632
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −20 467 40 933 −33,33
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 61 400 61 400
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −37 767 0 −100,00
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 20 467 132 978 18,19
2014-01-03 2013-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 37 767 129 619 41,12
2013-07-29 2013-07-25 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 75 000 75 000
2013-07-29 2013-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 5 082 91 852 5,86 7,81 39 690 717 364
2013-02-25 2013-02-22 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 77 500 77 500
2013-02-25 2013-02-22 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 106 000 106 000
2013-01-03 2012-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −37 767 37 768 −50,00
2013-01-03 2012-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes −16 410 86 770 −15,90 10,59 −173 782 918 894
2013-01-03 2012-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 37 767 103 180 57,74
2013-01-03 2012-12-26 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −1 500 65 413 −2,24
2012-11-02 2012-11-02 4 EXAS EXACT SCIENCES CORP
Common Stock
P - Purchase 2 000 66 913 3,08 9,13 18 260 610 916
2012-11-02 2012-11-01 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 3 277 64 913 5,32 5,48 17 958 355 723
2012-11-02 2012-04-30 4 EXAS EXACT SCIENCES CORP
Common Stock
A - Award 2 528 61 636 4,28 5,48 13 853 337 765
2012-11-02 2012-03-20 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −995 59 108 −1,66
2012-11-02 2012-03-05 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −2 115 60 103 −3,40
2012-02-29 2012-02-27 4 EXAS EXACT SCIENCES CORP
Stock Option (right to buy)
A - Award 127 500 127 500
2012-01-04 2011-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
M - Exercise −37 767 75 533 −33,33
2012-01-04 2011-12-31 4 EXAS EXACT SCIENCES CORP
Restricted Stock Units
A - Award 113 300 113 300
2012-01-04 2011-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
F - Taxes −16 410 62 218 −20,87 8,12 −133 249 505 210
2012-01-04 2011-12-31 4 EXAS EXACT SCIENCES CORP
Common Stock
M - Exercise 37 767 78 628 92,43
2012-01-04 2011-07-13 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −2 890 40 861 −6,61
2012-01-04 2011-07-05 4 EXAS EXACT SCIENCES CORP
Common Stock
G - Gift −2 919 43 751 −6,25
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)